Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase 3 study TROPION-Lung01

Akin Atmaca, Christian Schumann, Aaron Lisberg et al.|Pneumologie|2024

Cited by 3